| Bioactivity | Cap-dependent endonuclease-IN-7 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-7 Inhibits the synthesis of viral mRNA and eventually inhibits virus proliferation. Cap-dependent endonuclease-IN-7 has the potential for the research of viral infections (including influenza A, influenza B and influenza C) (extracted from patent WO2020177715A1, compound 5)[1] |
| Name | Cap-dependent endonuclease-IN-7 |
| CAS | 2485715-97-5 |
| Formula | C36H28FN3O7S |
| Molar Mass | 665.69 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Qingyun Ren, et al. Influenza virus replication inhibitor and use thereof. Patent WO2020177715A1. |
Cap-dependent endonuclease-IN-7
CAS: 2485715-97-5 F: C36H28FN3O7S W: 665.69
Cap-dependent endonuclease-IN-7 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.